Stockreport

COGT Reports Full Year 2023 Financial Results and Business Highlights [Yahoo! Finance]

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations
PDF Research and Development Expenses : R&D expenses increased to $173.8 million in 2023 from $121.6 million in 2022. General and Administrative Expenses : G&A expenses r [Read more]